Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha
about
Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytesThe g0/g1 switch gene 2 is an important regulator of hepatic triglyceride metabolism.Treatment with ginger ameliorates fructose-induced Fatty liver and hypertriglyceridemia in rats: modulation of the hepatic carbohydrate response element-binding protein-mediated pathway.NAMPT knockdown attenuates atherosclerosis and promotes reverse cholesterol transport in ApoE KO mice with high-fat-induced insulin resistance.The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndromePeripheral neuropathy in ART-experienced patients: prevalence and risk factorsFenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway.Interplay between statins and PPARs in improving cardiovascular outcomes: a double-edged sword?PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α.Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathwayFenofibrate attenuates impaired ischemic preconditioning-mediated cardioprotection in the fructose-fed hypertriglyceridemic rat heart.
P2860
Q28730590-05985CE2-9515-4E8E-B221-A17A820AD763Q34951495-DFBCE005-D1F2-4CE3-8EA1-FF1FCF525F99Q36411221-61D7DCDD-AAE9-49BF-AA62-09746CD95511Q36941601-E23CCFEE-5635-47BA-ACAF-614614930F87Q37363449-7F190BB0-6C65-4973-9DB2-9CF19A5916CFQ37662415-5BD4B82D-B944-43D9-8F73-E0B196DB1DD6Q37686153-DCB1A364-8F12-40A2-BD6B-D9BF42DD54A8Q37905844-3888C380-360D-43FD-BA91-AD77C1CF0FE0Q38674742-EBFAE8CF-E68C-4A9B-B7EC-9D7771AB334AQ42362094-AF0B4593-4FDC-414A-A932-BE848A861544Q54456708-7CFC0118-5CF3-4E53-A94B-729BA96C60EC
P2860
Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha
description
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2009
@ast
im Oktober 2009 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2009/10/01)
@sk
vědecký článek publikovaný v roce 2009
@cs
wetenschappelijk artikel (gepubliceerd op 2009/10/01)
@nl
наукова стаття, опублікована в жовтні 2009
@uk
مقالة علمية (نشرت في أكتوبر 2009)
@ar
name
Atorvastatin and fenofibrate i ...... rator-activated receptor-alpha
@ast
Atorvastatin and fenofibrate i ...... rator-activated receptor-alpha
@en
Atorvastatin and fenofibrate i ...... rator-activated receptor-alpha
@nl
type
label
Atorvastatin and fenofibrate i ...... rator-activated receptor-alpha
@ast
Atorvastatin and fenofibrate i ...... rator-activated receptor-alpha
@en
Atorvastatin and fenofibrate i ...... rator-activated receptor-alpha
@nl
prefLabel
Atorvastatin and fenofibrate i ...... rator-activated receptor-alpha
@ast
Atorvastatin and fenofibrate i ...... rator-activated receptor-alpha
@en
Atorvastatin and fenofibrate i ...... rator-activated receptor-alpha
@nl
P2093
P2860
P3181
P1476
Atorvastatin and fenofibrate i ...... rator-activated receptor-alpha
@en
P2093
Qian Zhang
Shui-ping Zhao
Xian-sheng Huang
P2860
P304
P3181
P356
10.1111/J.1476-5381.2009.00350.X
P407
P577
2009-10-01T00:00:00Z